CORC

在结果中检索

CORC

浏览/检索结果: 共166条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
A phase Ib/II study of AK112, a PD-1/VEGF bispecific antibody, as first- or second-line therapy for advanced non-small cell lung cancer (NSCLC). 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Zhou, Caicun;  Ren, Shengxiang;  Luo, Yongzhong;  Wang, Lei;  Xiong, Anwen
收藏  |  浏览/下载：11/0  |  提交时间：2022/12/23
Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker 期刊论文
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 卷号: 8, 期号: 2, 页码: 10
作者:  He, Bingxi;  Dong, Di;  She, Yunlang;  Zhou, Caicun;  Fang, Mengjie
收藏  |  浏览/下载：19/0  |  提交时间：2020/08/24
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2019, 卷号: 14, 期号: 5
作者:  Wu, Yi-Long;  Lu, Shun;  Cheng, Ying;  Zhou, Caicun;  Wang, Jie
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05
Tumor neoantigens: from basic research to clinical applications 期刊论文
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 卷号: 12, 期号: 1
作者:  Jiang, Tao;  Shi, Tao;  Zhang, Henghui;  Hu, Jie;  Song, Yuanlin
收藏  |  浏览/下载：13/0  |  提交时间：2019/12/05
Erlotinib versus gemcitabine/cisplatin in Chinese patients with EGFR mutation-positive advanced non-small-cell lung cancer: Crossover extension and post-hoc analysis of the ENSURE study 期刊论文
LUNG CANCER, 2019, 卷号: 130
作者:  Wu, Yi-Long;  Zhou, Caicun;  Lu, Shun;  Qin, Shukui;  Pan, Hongming
收藏  |  浏览/下载：22/0  |  提交时间：2019/12/05
Erlotinib versus gemcitabine/cisplatin in Chinese patients with EGFR mutation-positive advanced non-small-cell lung cancer: Crossover extension and post-hoc analysis of the ENSURE study 期刊论文
LUNG CANCER, 2019, 卷号: 130, 页码: 18-24
作者:  Wu, Yi-Long;  Zhou, Caicun;  Lu, Shun;  Qin, Shukui;  Pan, Hongming
收藏  |  浏览/下载：28/0  |  提交时间：2019/11/19
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced Non-Small Cell Lung Cancer: CheckMate 078 Randomized Phase III Clinical Trial 期刊论文
Journal of Thoracic Oncology, 2019
作者:  Yi-Long Wu;  Shun Lu;  Ying Cheng;  Caicun Zhou;  Jie Wang
收藏  |  浏览/下载：15/0  |  提交时间：2019/02/25
Erlotinib versus gemcitabine/cisplatin in Chinese patients with EGFR mutation-positive advanced non-small-cell lung cancer: Crossover extension and post-hoc analysis of the ENSURE study 期刊论文
Lung Cancer, 2019, 卷号: Vol.130, 页码: 18-24
作者:  Yi-Long Wu;  Caicun Zhou;  Shun Lu;  Shukui Qin;  Hongming Pan
收藏  |  浏览/下载：15/0  |  提交时间：2019/12/17
Asian  Chemotherapy  EGFR  Erlotinib  Non  small  cell  lung  cancer  
Surufatinib in Advanced Well-Differentiated Neuroendocrine Tumors: A Multicenter, Single-Arm, Open-Label, Phase Ib/II Trial 期刊论文
2019, 卷号: 25, 期号: 12, 页码: 3486-3494
作者:  Xu, Jianming;  Li, Jie;  Bai, Chunmei;  Xu, Nong;  Zhou, Zhiwei
收藏  |  浏览/下载：23/0  |  提交时间：2020/01/03
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial 期刊论文
2019, 卷号: 14, 期号: 5, 页码: 867-875
作者:  Wu, Yi-Long;  Lu, Shun;  Cheng, Ying;  Zhou, Caicun;  Wang, Jie
收藏  |  浏览/下载：14/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace